DAFTAR PUSTAKA
1. Jessop S, Khumalo NP. Pemphigus, a treatment update. Am J Clin Dermatol.
2008;9:147-54.
2. Alsaleh QA, Nanda A, Al-Baghli NM, Dvorak R. Pemphigus in Kuwait.
International Journal of Dermatology. 1999;38:351-6.
3. Black M, Mignogna MD, Scully C. Number II Pemphigus vulgaris. Oral
Diseases. 2005;11:119-30.
4. Stanley JR. Pemphigus. Dalam: Wolff K, Goldsmith LA, Katz SI, Gilchrest
BA, Paller AS, Leffell DJ, editors. Fitzpatricks Dermatology in general
medicine. Edisi ke-7. New york. McGraw-Hill; 2008.h.459-68.
5. Wojnarowska F, Venning VA, Burge SM. Immunobullous diseases. Dalam :
Burns T, Breathnatch S, Cox N, Griffiths C. Rooks Textbook of
Dermatology. Edisi ke-7. USA:Blackwell; 2004.h. 41.1-59.
6. Kavusi S, Daneshpazhooh M, Farahani F, Abedini R, Lajevardi V, Davatchi
CC. Outcome of pemphigus vulgaris. European Academy of Dermatology and
Venereology. 2008;22:580-4.
7. Davatchi CC, Valikhani M, Daneshpazhooh M, Esmaili N, Balighi K, Hallaji
Z, Barzegari M, Akhiani M, Ghodsi Z, Mortazavi H, Naraghi Z. Pemphigus :
Analysis of 1209 cases. International Journal of Dermatology. 2005;44:470-6.
8. Yeh SW, Ahmed B, Sami N, Ahmed AR. Blistering disorders: diagnosis and
treatment. Dermatologic therapy. 2003;16:214-33.
9. Bickle KM, Roark TR, Hsu S. Autoimmune Bullous Dermatoses : A review.
American Family Physician. 2002;65:1861-70.
10. Mutasim DF, Bilic M, Hawayek LH, Pipitone MA, Sluzevich JC.
Immunobullous diseases. Journal of the American Academy of Dermatology.
2005;52:1029-43.
11. James WD, Berger TG, Elston DM. Chronic Blistering Dermatoses. Dalam :
Andrews Disease of the skin Clinical Dermatology. Edisi ke-10. Canada: WB
Saunders Company. 2006.h.459-62.
12. Ruocco V, Ruocco E. Pemphigus and environmental factors. Gital Dermatol.
Venereol. 2003;138:299-309.
13. Ruocco E, Aurilia A, Ruocco V. Precautions and suggestions for pemphigus
[Link] 2001;203:201-7
14. Singal A, Panhi D, Localized pemphigus vulgaris on cheeks responding to
topical steroid. IndianJ Dermatol veneoreol .2009;75: 80-1
15. Kloudova M, Kopacopa M, Slezak R,dkk. Serious oesophageal involvement
in a young female patient with pemhigus vulgaris. Folia Gastroenterol.
2004;2:133-8.
Universitas Sumatera Utara
16. Wolh Y, Brenner S. Pemphigus in Israel-an epidemiologic Analysis of cases
in search of risk factors. Imay. 2003;5:410-12.
17. Fisher, KR, Higginbotham R, Frey J, Granese J,Pillow J, Skinner RB.
Pesticide-associate pemphigus [Link] of medicine, Division of
dermotogy. 2008;82:51-4.
18. Hidayat T, Isramiharti, Lestari. Profil pemfigus vulgaris di rs. Dr. M. Djamil
Padang periode 2004-2008. Buku makalah lengkap II PIT X PERDOSKI;
2009 Oktober 29-31; Banten;2009. h.9-12.
19. Sharma P, Mao X, Payne AS. Beyond steric hindrance : The role of adhesion
signaling pathways in the pathogenesis of pemphigus. Journal of Derm
Science. 2007;48:1-14.
20. Wu H, Schapiro B, Harrist TJ. Non infectious vesicobullous and
vesicopustular diseases. Dalam : Elder D, Johnson B, Elenitsas R. Dalam :
Lever s histopathology of the [Link] ke-9. Philadelphia: LippincottRaven. 2005;9:243-91.
21. Mutasim DF, Adams BB. Immunofluorescence in dermatology. Journal of the
American Academy of Dermatology. 2001;45:803-22.
22. Mutasim DF. Management of autoimmune bullous diseases: Pharmacology
and therapeutics. Journal of the American Academy of Dermatology.
2004;51:859-77.
23. Chaidemeros G Ch, Mourellou O, Koussidou T, Tsatsou F. An alternate-day
corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
European Academy of Dermatology and Venereology. 2007;21: 1386-91.
Universitas Sumatera Utara